Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine

article

Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VACCINE.2018.10.031
P698PubMed publication ID30327212

P50authorBarbara J KamickerQ73173577
P2093author name stringDouglas E Brough
Bryan T Butman
Damodar Ettyreddy
William Hurtle
Carla Bravo de Rueda
Christopher Schutta
David A Brake
John G Neilan
José Barrera
Melia Pisano
Max V Rasmussen
Mariceny Zurita
Bruce G Harper
P2860cites workReview of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014.Q30252156
Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005.Q36372790
A continuous bovine kidney cell line constitutively expressing bovine αvβ6 integrin has increased susceptibility to foot-and-mouth disease virusQ37026441
Experimental infections using the foot-and-mouth disease virus O/JPN/2010 in animals administered a vaccine preserved for emergency use in JapanQ37621349
Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in TurkeyQ37709740
Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in CattleQ38280242
Epidemiology of the Foot-and-Mouth Disease Serotype O Epidemic of November 2010 to April 2011 in the Republic Of KoreaQ38449823
Foot-and-Mouth Disease Impact on Smallholders - What Do We Know, What Don't We Know and How Can We Find Out More?Q38831972
Global Foot-and-Mouth Disease Research Update and Gap Analysis: 2 - Epidemiology, Wildlife and Economics.Q38851221
Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012.Q38863587
Foot-and-mouth disease virus serotype A in EgyptQ39142159
Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swineQ39944822
Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccinationQ40090235
Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattleQ40158399
Detailed analysis of the CD8+ T-cell response following adenovirus vaccinationQ40344509
Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swineQ40389704
Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virusQ40580981
Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from EcuadorQ40659903
Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.Q40856278
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidateQ40920483
Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccinationQ41281277
Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011.Q42228510
Correction for LaRocco et al., A Continuous Bovine Kidney Cell Line Constitutively Expressing Bovine αVβ6 Integrin Has Increased Susceptibility to Foot-and-Mouth Disease VirusQ43110569
Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.Q45225160
Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattleQ45325592
Recent spread of a new strain (A-Iran-05) of foot-and-mouth disease virus type A in the Middle EastQ45384620
Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far EastQ47160644
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccineQ47550239
Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.Q50532178
Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs.Q51785051
The need for improved vaccines against foot-and-mouth disease.Q52653907
Multimodel Inference: Understanding AIC and BIC in Model SelectionQ56390541
An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virusQ57092099
Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserveQ57098605
P433issue48
P407language of work or nameEnglishQ1860
P921main subjectfoot-and-mouth disease virusQ1911079
foot-and-mouth diseaseQ152401
AdenoviridaeQ193447
P304page(s)7345-7352
P577publication date2018-10-13
P1433published inVaccineQ7907941
P1476titleVersatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine
P478volume36